BioViva Company

BioViva’s core gene therapy technology is the subject of a pending patent application. Among other things, this includes aspects of the fundamental recombinant viral vectors and treatment methods that have been shown to significantly increase longevity, prevent age-related hair loss, increase blood glucose tolerance, increase physical coordination, reduce age-related weight loss, and reverse signs of mitochondrial dysfunction
Technology: Regenerative Medicine
Industry: Gene therapy, Mitochondrial Genetics
Headquarters: USA
Founded Date: Jan 5, 2015
Employees Number: 1-10
Funding Status: Equity Crowdfunding
Total Funding: 250K
Last Funding Date: Jul 15, 2015
Last Funding Type: Equity Crowdfunding

Visit Website
Register and Claim Ownership